Our goal has been to define the important molecular events that control T cell maturation within the thymus. Within the thymus, hematopoietic precursor cells undergo a complex set of developmental events and emerge as mature T lymphocytes capable of specific antigen recognition. This developmental process appears to result from a series of signalling interactions between T cell precursors and a heterogeneous and as yet ill-defined set of stromal cells. In addition to T cells, a class of cytotoxic lymphocytes known as """"""""natural killer"""""""" cells, which play potentially important roles in immune responses against cancerous or virally-infected cells, can also develop in the thymus. We are taking two approaches to thymic development at the molecular level. First, we have established a culture system in which day 14/15 triple negative fetal thymocytes can be stimulated to express early markers of thymocyte development including CD25, ICAM-1, and Ly-6A/E. We are studying the molecular signals that activate this early developmental step. During these studies we have discovered a novel precursor cell that gives rise to both T lymphocytes and natural killer cells. We have also obtained evidence for a novel developmental pathway that allows triple negative thymocytes to develop into double positive thymocytes. Second, we are creating genetically-engineered mice that are homozygous-deficient (knocked-out) for various genes that are highly expressed in thymocytes. We are currently focusing on three genes: i) Ly-GDI - a GDP-dissociation inhibitor protein that controls the activity of Rho, a member of the Ras family that may be involved in molecular signalling cascades; ii) Rlk - a newly described member of the btk/itk family of tyrosine kinases that have been recently implicated in inherited immunodeficiency states and are involved in signalling from surface antigen receptors; and iii) Ntk - a newly-described tyrosine kinase related to the Csk kinase that regulates various Src family kinases by phosphorylating inhibitory tyrosine residues. Since signalling interactions are critical for proper T cell differentiation, disruption of these signalling molecules may inhibit T cell development in ways that clarify the normal physiological roles of these molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000627-03
Application #
3746614
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Ozen, Ahmet; Comrie, William A; Ardy, Rico C et al. (2017) CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med 377:52-61
Schaeffer, E M; Debnath, J; Yap, G et al. (1999) Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284:638-41
Jiang, D; Zheng, L; Lenardo, M J (1999) Caspases in T-cell receptor-induced thymocyte apoptosis. Cell Death Differ 6:402-11
Debnath, J; Chamorro, M; Czar, M J et al. (1999) rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol Cell Biol 19:1498-507